- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Poliovirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Poliovirus Vaccine market size is estimated to be worth US$ 730.3 million in 2021 and is forecast to a readjusted size of USD 957.4 million by 2028 with a CAGR of 3.9% during review period. Public accounting for % of the Poliovirus Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inactivated Polio Vaccine (IPV) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Poliovirus Vaccine include Sanofi, GSK, Bibcol, Serum Institute, and Tiantan Biological, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Poliovirus Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Market segment by Application can be divided into
Public
Private
The key market players for global Poliovirus Vaccine market are listed below:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Poliovirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Poliovirus Vaccine, with price, sales, revenue and global market share of Poliovirus Vaccine from 2019 to 2022.
Chapter 3, the Poliovirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poliovirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Poliovirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Poliovirus Vaccine.
Chapter 13, 14, and 15, to describe Poliovirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Poliovirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Poliovirus Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market Analysis by Application
1.3.1 Overview: Global Poliovirus Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Public
1.3.3 Private
1.4 Global Poliovirus Vaccine Market Size & Forecast
1.4.1 Global Poliovirus Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Poliovirus Vaccine Sales in Volume (2017-2028)
1.4.3 Global Poliovirus Vaccine Price (2017-2028)
1.5 Global Poliovirus Vaccine Production Capacity Analysis
1.5.1 Global Poliovirus Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Poliovirus Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Poliovirus Vaccine Market Drivers
1.6.2 Poliovirus Vaccine Market Restraints
1.6.3 Poliovirus Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Poliovirus Vaccine Product and Services
2.1.4 Sanofi Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Poliovirus Vaccine Product and Services
2.2.4 GSK Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Poliovirus Vaccine Product and Services
2.3.4 Bibcol Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Serum Institute
2.4.1 Serum Institute Details
2.4.2 Serum Institute Major Business
2.4.3 Serum Institute Poliovirus Vaccine Product and Services
2.4.4 Serum Institute Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Poliovirus Vaccine Product and Services
2.5.4 Tiantan Biological Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 IMBCA
2.6.1 IMBCA Details
2.6.2 IMBCA Major Business
2.6.3 IMBCA Poliovirus Vaccine Product and Services
2.6.4 IMBCA Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Panacea Biotec Ltd
2.7.1 Panacea Biotec Ltd Details
2.7.2 Panacea Biotec Ltd Major Business
2.7.3 Panacea Biotec Ltd Poliovirus Vaccine Product and Services
2.7.4 Panacea Biotec Ltd Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Poliovirus Vaccine Product and Services
2.8.4 Bio-Med Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business
2.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product and Services
2.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Poliovirus Vaccine Breakdown Data by Manufacturer
3.1 Global Poliovirus Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Poliovirus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Poliovirus Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Poliovirus Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Poliovirus Vaccine Manufacturer Market Share in 2021
3.5 Global Poliovirus Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Poliovirus Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Poliovirus Vaccine Market Size by Region
4.1.1 Global Poliovirus Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Poliovirus Vaccine Revenue by Region (2017-2028)
4.2 North America Poliovirus Vaccine Revenue (2017-2028)
4.3 Europe Poliovirus Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Poliovirus Vaccine Revenue (2017-2028)
4.5 South America Poliovirus Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Poliovirus Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Poliovirus Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Poliovirus Vaccine Revenue by Type (2017-2028)
5.3 Global Poliovirus Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Poliovirus Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Poliovirus Vaccine Revenue by Application (2017-2028)
6.3 Global Poliovirus Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Poliovirus Vaccine Sales by Type (2017-2028)
7.2 North America Poliovirus Vaccine Sales by Application (2017-2028)
7.3 North America Poliovirus Vaccine Market Size by Country
7.3.1 North America Poliovirus Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Poliovirus Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Poliovirus Vaccine Sales by Type (2017-2028)
8.2 Europe Poliovirus Vaccine Sales by Application (2017-2028)
8.3 Europe Poliovirus Vaccine Market Size by Country
8.3.1 Europe Poliovirus Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Poliovirus Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Poliovirus Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Poliovirus Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Poliovirus Vaccine Market Size by Region
9.3.1 Asia-Pacific Poliovirus Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Poliovirus Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Poliovirus Vaccine Sales by Type (2017-2028)
10.2 South America Poliovirus Vaccine Sales by Application (2017-2028)
10.3 South America Poliovirus Vaccine Market Size by Country
10.3.1 South America Poliovirus Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Poliovirus Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Poliovirus Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Poliovirus Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Poliovirus Vaccine Market Size by Country
11.3.1 Middle East & Africa Poliovirus Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Poliovirus Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Poliovirus Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Poliovirus Vaccine
12.3 Poliovirus Vaccine Production Process
12.4 Poliovirus Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Poliovirus Vaccine Typical Distributors
13.3 Poliovirus Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Poliovirus Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Poliovirus Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Poliovirus Vaccine Product and Services
Table 6. Sanofi Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Poliovirus Vaccine Product and Services
Table 10. GSK Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bibcol Basic Information, Manufacturing Base and Competitors
Table 12. Bibcol Major Business
Table 13. Bibcol Poliovirus Vaccine Product and Services
Table 14. Bibcol Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 16. Serum Institute Major Business
Table 17. Serum Institute Poliovirus Vaccine Product and Services
Table 18. Serum Institute Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 20. Tiantan Biological Major Business
Table 21. Tiantan Biological Poliovirus Vaccine Product and Services
Table 22. Tiantan Biological Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. IMBCA Basic Information, Manufacturing Base and Competitors
Table 24. IMBCA Major Business
Table 25. IMBCA Poliovirus Vaccine Product and Services
Table 26. IMBCA Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Panacea Biotec Ltd Major Business
Table 29. Panacea Biotec Ltd Poliovirus Vaccine Product and Services
Table 30. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 32. Bio-Med Major Business
Table 33. Bio-Med Poliovirus Vaccine Product and Services
Table 34. Bio-Med Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Halfkin Bio-Pharmaceuticals Major Business
Table 37. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product and Services
Table 38. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Poliovirus Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Poliovirus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Poliovirus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Poliovirus Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Poliovirus Vaccine Production Site of Key Manufacturer
Table 44. Poliovirus Vaccine New Entrant and Capacity Expansion Plans
Table 45. Poliovirus Vaccine Mergers & Acquisitions in the Past Five Years
Table 46. Global Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 47. Global Poliovirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 48. Global Poliovirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Poliovirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 51. Global Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 52. Global Poliovirus Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Poliovirus Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Poliovirus Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Poliovirus Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 57. Global Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 58. Global Poliovirus Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Poliovirus Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Poliovirus Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Poliovirus Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 63. North America Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 64. North America Poliovirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Poliovirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. North America Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. North America Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. North America Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. Europe Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 71. Europe Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 72. Europe Poliovirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Poliovirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 75. Europe Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 76. Europe Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Europe Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Poliovirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Poliovirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Poliovirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 86. South America Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 87. South America Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 88. South America Poliovirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Poliovirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 91. South America Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 92. South America Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 93. South America Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Poliovirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Poliovirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Poliovirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 102. Poliovirus Vaccine Raw Material
Table 103. Key Manufacturers of Poliovirus Vaccine Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Poliovirus Vaccine Typical Distributors
Table 107. Poliovirus Vaccine Typical Customers
List of Figures
Figure 1. Poliovirus Vaccine Picture
Figure 2. Global Poliovirus Vaccine Revenue Market Share by Type in 2021
Figure 3. Inactivated Polio Vaccine (IPV)
Figure 4. Oral Polio Vaccine (OPV)
Figure 5. Global Poliovirus Vaccine Revenue Market Share by Application in 2021
Figure 6. Public
Figure 7. Private
Figure 8. Global Poliovirus Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Poliovirus Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Poliovirus Vaccine Sales (2017-2028) & (K Units)
Figure 11. Global Poliovirus Vaccine Price (2017-2028) & (USD/Unit)
Figure 12. Global Poliovirus Vaccine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Poliovirus Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Poliovirus Vaccine Market Drivers
Figure 15. Poliovirus Vaccine Market Restraints
Figure 16. Poliovirus Vaccine Market Trends
Figure 17. Global Poliovirus Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global Poliovirus Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Poliovirus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Poliovirus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global Poliovirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Poliovirus Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Poliovirus Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Poliovirus Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global Poliovirus Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Poliovirus Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America Poliovirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Poliovirus Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe Poliovirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Poliovirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America Poliovirus Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America Poliovirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Poliovirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Poliovirus Vaccine in 2021
Figure 76. Manufacturing Process Analysis of Poliovirus Vaccine
Figure 77. Poliovirus Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
